Reasons for Lost to Follow-up of People Living with HIV on Antiretroviral Therapy in Bhavnagar
DOI:
https://doi.org/10.3126/jcms.v22i2.76613Keywords:
HIV Infections, Highly active antiretroviral therapy, Patient dropouts, IndiaAbstract
Background
Anti-retroviral therapy (ART) aims to achieve sustained viral suppression and immune restoration. Understanding reasons for loss-to-follow-up (LFU) and associated factors is essential to improve adherence interventions and strengthen HIV care outcomes. The study amied to assess the profile of lost-to-follow-up people living with HIV on antiretroviral therapy at the ART Plus Centre of Sir Takhtsinhji Hospital, Bhavnagar, and to explore the reasons for loss to follow-up.
Methods
A mixed-method study was conducted from November 2022 to March 2023 at the ART Plus Centre. Data regarding 263 PLHIV patients who were lost to follow-up during the previous five years (2018-22) were obtained from the ART Plus Center Bhavnagar. Qualitative data were collected through face-to-face interviews using in-depth interview (IDI) guides among 19 purposively selected participants. Quantitative data were summarised using frequencies, while thematic analysis was performed for the qualitative component.
Results
A majority of the LFU patients (40.97%) were from Bhavnagar taluka. Migration was found to be a major factor (33.33%) for lost-to-follow-up patients, followed by inability to track due to an incorrect address given by patients (30.85%) and death (4.48%) on secondary data analysis. Factors related to four main themes socio-economic, work-related, medication and ART centre related were reported as reasons for lost to follow-up in a qualitative study.
Conclusions
The major reasons for lost-to-follow-up as perceived by LFU PLHIVs of Bhavnagar were no felt need of medicine, side effects of medicine and poor support from the ART centre.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 The Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This license enables reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.